These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 33152422)

  • 1. Molecular characteristics of porcine alpha-synuclein splicing variants.
    Larsen K; Bæk R; Sahin C; Kjær L; Christiansen G; Nielsen J; Farajzadeh L; Otzen DE
    Biochimie; 2021 Jan; 180():121-133. PubMed ID: 33152422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an Alternatively Spliced α-Synuclein Isoform That Generates a 41-Amino Acid N-Terminal Truncated Peptide, 41-syn: Role in Dopamine Homeostasis.
    Vinnakota RL; Yedlapudi D; Manda KM; Bhamidipati K; Bommakanti KT; RangaLakshmi GS; Kalivendi SV
    ACS Chem Neurosci; 2018 Dec; 9(12):2948-2958. PubMed ID: 29996045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcript expression levels of full-length alpha-synuclein and its three alternatively spliced variants in Parkinson's disease brain regions and in a transgenic mouse model of alpha-synuclein overexpression.
    McLean JR; Hallett PJ; Cooper O; Stanley M; Isacson O
    Mol Cell Neurosci; 2012 Feb; 49(2):230-9. PubMed ID: 22155155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of RBMX as a splicing regulator in Parkinsonian mimetic induced alternative splicing of α-synuclein.
    Thonda S; Vinnakota RL; Kona SV; Kalivendi SV
    Biochim Biophys Acta Gene Regul Mech; 2022 May; 1865(4):194825. PubMed ID: 35577270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations.
    Sahay S; Ghosh D; Singh PK; Maji SK
    Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splicing variants of porcine synphilin-1.
    Larsen K; Madsen LB; Farajzadeh L; Bendixen C
    Meta Gene; 2015 Sep; 5():32-42. PubMed ID: 26101749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis.
    Mehra S; Sahay S; Maji SK
    Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):890-908. PubMed ID: 30853581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Druggable Genome Screen Identifies Modifiers of α-Synuclein Levels via a Tiered Cross-Species Validation Approach.
    Rousseaux MWC; Vázquez-Vélez GE; Al-Ramahi I; Jeong HH; Bajić A; Revelli JP; Ye H; Phan ET; Deger JM; Perez AM; Kim JY; Lavery LA; Xu Q; Li MZ; Kang H; Kim JJ; Shulman JM; Westbrook TF; Elledge SJ; Liu Z; Botas J; Zoghbi HY
    J Neurosci; 2018 Oct; 38(43):9286-9301. PubMed ID: 30249792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases.
    Beyer K; Domingo-Sábat M; Lao JI; Carrato C; Ferrer I; Ariza A
    Neurogenetics; 2008 Feb; 9(1):15-23. PubMed ID: 17955272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chaperone-like activity of α-synuclein attenuates aggregation of its alternatively spliced isoform, 112-synuclein in vitro: plausible cross-talk between isoforms in protein aggregation.
    Manda KM; Yedlapudi D; Korukonda S; Bojja S; Kalivendi SV
    PLoS One; 2014; 9(6):e98657. PubMed ID: 24892822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Analysis of the Conformation, Aggregation, Interaction, and Fibril Morphologies of Human α-, β-, and γ-Synuclein Proteins.
    Jain MK; Singh P; Roy S; Bhat R
    Biochemistry; 2018 Jul; 57(26):3830-3848. PubMed ID: 29851342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence- and seed-structure-dependent polymorphic fibrils of alpha-synuclein.
    Tanaka G; Yamanaka T; Furukawa Y; Kajimura N; Mitsuoka K; Nukina N
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1410-1420. PubMed ID: 30790619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-SUMOylated alternative spliced isoforms of alpha-synuclein are more aggregation-prone and toxic.
    Hassanzadeh K; Morrone C; Akhtari K; Gerhardt E; Zaccagnini L; Outeiro TF; Feligioni M
    Mech Ageing Dev; 2023 Jan; 209():111759. PubMed ID: 36464085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cloning, genomic organization, chromosome mapping, tissues expression pattern and identification of a novel splicing variant of porcine CIDEb gene.
    Li Y; Li A; Yang ZQ
    Biochem Biophys Res Commun; 2016 Sep; 478(1):486-493. PubMed ID: 27207838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-terminal α-synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease.
    McGlinchey RP; Lacy SM; Huffer KE; Tayebi N; Sidransky E; Lee JC
    J Biol Chem; 2019 Jun; 294(25):9973-9984. PubMed ID: 31092553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain.
    Bergeron M; Motter R; Tanaka P; Fauss D; Babcock M; Chiou SS; Nelson S; San Pablo F; Anderson JP
    Neuroscience; 2014 Jan; 256():72-82. PubMed ID: 24128992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion in exon 5 of the SNCA gene and exposure to rotenone leads to oligomerization of α-synuclein and toxicity to PC12 cells.
    Ma KL; Song LK; Long WA; Yuan YH; Zhang Y; Song XY; Niu F; Han N; Chen NH
    Brain Res Bull; 2013 Jan; 90():127-31. PubMed ID: 23128054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.
    Lee MK; Stirling W; Xu Y; Xu X; Qui D; Mandir AS; Dawson TM; Copeland NG; Jenkins NA; Price DL
    Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8968-73. PubMed ID: 12084935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease.
    Faustini G; Longhena F; Varanita T; Bubacco L; Pizzi M; Missale C; Benfenati F; Björklund A; Spano P; Bellucci A
    Acta Neuropathol; 2018 Oct; 136(4):621-639. PubMed ID: 30046897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
    Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.